Investor Hub
Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases.
Historical stock price
Select the date below for the historical closing price for that particular day.
The closing price is not indicative of future price performance. Historical Stock Prices are provided for informational purposes only and are not intended for trading purposes.
Select A Date
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
B. Riley FBR
Cantor Fitzgerald
Cowen
H.C. Wainwright & Co.
Jefferies
JP Morgan
The analysts listed on this page follow Novavax. Please note that any opinions, estimates or forecasts regarding Novavax' performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Novavax or its management. Novavax does not by its reference above or distribution imply its endorsements of or concurrence with such information, conclusions or recommendations.
 |
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
 |
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.